Overview

Study Evaluating ECG Effects, Safety, Tolerability and Pharmacokinetics of Single Doses of Modufolin (Arfolitixorin) in Healthy Volunteers Tetrahydrofolate in Healthy Male Volunteers

Status:
Completed

Trial end date:
2017-08-25

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluating ECG effects, safety, tolerability and pharmacokinetics of single ascending dose of Modufolin® in healthy male volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Isofol Medical AB

Treatments:

Tetrahydrofolates